Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
Journal of Psoriasis and Psoriatic Arthritis
|
June 12, 2026
Ixekizumab Treatment Persistence in Psoriatic Arthritis: Response to Joaquin et al
Camilla Mazzanti, Marino Paroli, Gianluca Santoboni, et al.
Journal of Psoriasis and Psoriatic Arthritis
|
May 16, 2025
Ixekizumab Retention Rate and Predictors of Treatment Persistence in Psoriatic Arthritis: Results of an Italian Multicenter Study
Camilla Mazzanti, Marino Paroli, Gianluca Santoboni, et al.
Mediterranean Journal of Rheumatology
|
June 29, 2026
Real-World Effectiveness of Baricitinib in Rheumatoid Arthritis: Significant Reduction of Disease Activity Independent of Age in a Multicentre Retrospective Cohort Study
Daniele Lini, Matteo Colina, Romina Andracco, et al.
Scientific Reports
|
June 2, 2026
Six months predictors of DAPSA Remission With Guselkumab in Psoriatic Arthritis in a Multicenter Real-World Study
Alessandro Conforti, Alarico Ariani, Martina Gentile, et al.
Rheumatology Advances in Practice
|
September 22, 2025
Guselkumab effectiveness in real-world settings: observations from an Italian multicentre study
Andrea Becciolini, Antonio Marchesoni, Simone Parisi, et al.
Rheumatology and Therapy
|
March 14, 2026
Does Prior Exposure Affect Retention? A Real-World, Multicentre Assessment of IL-17 Inhibitor Cycling in Psoriatic Arthritis
Valentino Paci, Alarico Ariani, Eleonora Celletti, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
Journal of Psoriasis and Psoriatic Arthritis
|
June 12, 2026
Ixekizumab Treatment Persistence in Psoriatic Arthritis: Response to Joaquin et al
Camilla Mazzanti, Marino Paroli, Gianluca Santoboni, et al.
Journal of Psoriasis and Psoriatic Arthritis
|
May 16, 2025
Ixekizumab Retention Rate and Predictors of Treatment Persistence in Psoriatic Arthritis: Results of an Italian Multicenter Study
Camilla Mazzanti, Marino Paroli, Gianluca Santoboni, et al.
Mediterranean Journal of Rheumatology
|
June 29, 2026
Real-World Effectiveness of Baricitinib in Rheumatoid Arthritis: Significant Reduction of Disease Activity Independent of Age in a Multicentre Retrospective Cohort Study
Daniele Lini, Matteo Colina, Romina Andracco, et al.
Scientific Reports
|
June 2, 2026
Six months predictors of DAPSA Remission With Guselkumab in Psoriatic Arthritis in a Multicenter Real-World Study
Alessandro Conforti, Alarico Ariani, Martina Gentile, et al.
Rheumatology Advances in Practice
|
September 22, 2025
Guselkumab effectiveness in real-world settings: observations from an Italian multicentre study
Andrea Becciolini, Antonio Marchesoni, Simone Parisi, et al.
Rheumatology and Therapy
|
March 14, 2026
Does Prior Exposure Affect Retention? A Real-World, Multicentre Assessment of IL-17 Inhibitor Cycling in Psoriatic Arthritis
Valentino Paci, Alarico Ariani, Eleonora Celletti, et al.
Page
of 4